Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioequivalence Assessment Between Two Brivaracetam 100 mg Coated Tablet Formulations

NCT07800533 is registered in ClinicalTrials.gov with Zodiac Produtos Farmaceuticos S.A. as lead sponsor.

NCT NCT07800533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07800533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioequivalence Assessment Between Two Brivaracetam 100 mg Coated Tablet Formulations
Lead sponsor
Zodiac Produtos Farmaceuticos S.A.
Phase
Phase 1
Overall status
Completed
Start date
August 9, 2024
Completion date
August 19, 2024
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bioequivalence study in healthy subjects